Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Delta sleep-inducing peptide, immunoreactor pseudogene" (gene symbol ENSG00000236413, also known as LOC107985643) is listed in genomic databases as a **pseudogene** associated with the TSC22 domain protein family, containing sequence resemblance to leucine zipper-containing proteins and transcriptional regulators such as TSC22 domain family protein 3[1]. This pseudogene shares significant sequence similarity with the murine TSC-22 and Drosophila shs gene products and is sometimes referred to by aliases suggesting an association with the originally described **delta sleep-inducing peptide (DSIP)** and related immunoreactive proteins. Unlike the biologically active DSIP peptide or its putative protein immunoreactors, this entry represents a **pseudogene**—a non-functional gene copy—and is not known to encode a protein or act as a therapeutic target, receptor, enzyme, or transporter. **No direct biological or therapeutic function has been established for this pseudogene, and it is not a direct target for drugs or research into sleep regulation or related disorders**[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Delta sleep-inducing peptide, immunoreactor pseudogene.